BioTelemetry provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing, and centralized core laboratory services for clinical research. The Company operates in three segments: Healthcare, Research, and Technology. The Healthcare segment is focused on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. BioTelemetry offers cardiologists and electrophysiologists a full spectrum of solutions which provides them with a single source of cardiac monitoring services. These services range from the differentiated mobile cardiac telemetry service to the wireless and trans-telephonic event, traditional Holter, extended-wear Holter, Pacemaker and International Normalized Ratio monitoring. The Research segment is engaged in central core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials. The Technology segment focuses on the development, manufacturing, testing, and marketing of medical devices to medical companies, clinics, and hospitals.

Show more

Employee Rating

2.7More
TypePublic
HQMalvern, US
Founded2013
Size (employees)1,087 (est)+16%
Websitegobio.com
BioTelemetry was founded in 2013 and is headquartered in Malvern, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

BioTelemetry Office Locations

BioTelemetry has offices in Malvern, San Diego, Chiyoda-ku, London and in 8 other locations
Malvern, (HQ)
102 1000 Cedar Hollow Rd
Chester County,
Beacon Light Rd
Eagan,
150 1285 Corporate Center Dr
Eagan,
175 1285 Corporate Center Dr
Norfolk,
204 5700 Lake Wright Dr
Phoenix,
100 2750 S 18th Pl
Show all (13)
Report incorrect company information

BioTelemetry Financials and Metrics

BioTelemetry Revenue

BioTelemetry's revenue was reported to be $286.78 m in FY, 2017
USD

Revenue (Q3, 2018)

100.0m

Gross profit (Q3, 2018)

62.7m

Gross profit margin (Q3, 2018), %

62.7%

Net income (Q3, 2018)

16.0m

Market capitalization (4-Dec-2018)

2.3b

Closing stock price (4-Dec-2018)

68.2

Cash (30-Sep-2018)

63.1m

EV

2.4b
BioTelemetry's current market capitalization is $2.3 b.
Annual
usdFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

119.0m111.5m129.5m166.6m178.5m208.3m286.8m

Revenue growth, %

(6%)16%29%7%17%

Cost of goods sold

6.2m5.1m73.1m72.0m114.4m

Gross profit

112.8m106.4m93.5m106.6m172.4m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

31.9m37.2m42.7m43.1m43.4m44.8m43.5m48.6m52.7m53.1m55.9m58.1m81.0m94.5m101.4m100.0m

Cost of goods sold

12.6m15.5m19.0m19.4m18.2m18.1m17.2m18.0m19.8m20.2m23.0m22.2m32.0m36.4m35.6m37.3m

Gross profit

19.2m21.6m23.6m23.7m25.2m26.7m26.3m30.6m32.9m32.9m32.9m36.0m49.1m58.0m65.8m62.7m

Gross profit Margin, %

60%58%55%55%58%60%61%63%62%62%59%62%61%61%65%63%
Annual
usdY, 2010Y, 2011Y, 2012Y, 2013FY, 2013Y, 2014FY, 2015Y, 2015FY, 2016FY, 2017

Cash

18.7m18.3m18.3m22.2m22.2m20.0m19.0m19.0m23.1m36.0m

Accounts Receivable

Inventories

2.4m2.6m2.4m2.4m1.5m5.2m5.3m

Current Assets

44.3m44.3m49.5m47.0m47.0m59.6m90.1m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

21.0m12.0m13.5m12.2m12.3m14.8m15.5m22.8m25.4m32.3m25.1m26.9m26.2m36.3m39.4m63.1m

Inventories

3.4m3.0m3.0m2.6m3.0m3.2m2.8m2.9m3.5m3.8m4.3m4.1m6.1m6.4m7.7m8.8m

Current Assets

46.0m40.8m41.8m41.9m42.3m43.5m45.2m51.7m59.0m68.3m64.0m65.9m78.4m98.4m105.2m134.0m

PP&E

17.7m25.0m29.1m29.0m21.4m23.8m25.0m26.3m26.3m26.3m26.4m26.7m56.7m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(7.3m)(9.8m)7.4m53.4m(17.1m)

Depreciation and Amortization

12.3m12.6m12.5m14.3m28.6m

Inventories

340.0k299.0k188.0k(753.0k)665.0k

Accounts Payable

2.4m47.0k(4.7m)3.1m(9.6m)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

(7.3m)(4.1m)(8.1m)(8.1m)(69.0k)2.1m4.6m4.0m8.3m12.4m196.0k1.9m(642.0k)5.0m15.5m31.5m

Depreciation and Amortization

9.5m2.8m6.0m9.2m3.0m6.0m9.1m3.3m6.9m10.6m3.7m7.5m16.6m9.8m19.9m30.2m

Inventories

(520.0k)(104.0k)(104.0k)307.0k(456.0k)(640.0k)(241.0k)(487.0k)(786.0k)(1.2m)810.0k845.0k(89.0k)(1.0m)(2.4m)(3.5m)

Accounts Payable

2.0m1.8m1.3m(402.0k)(1.2m)(1.2m)(2.7m)1.9m1.8m934.0k463.0k(3.2m)(8.7m)2.3m(582.0k)1.1m
USDY, 2018

EV/CFO

54.4 x

Debt/Equity

0.7 x

Debt/Assets

0.3 x

Financial Leverage

1.9 x
Show all financial metrics

BioTelemetry Operating Metrics

FY, 2015FY, 2016

Patents (Foreign)

81 111

Patents (US)

34 49

Patents Issued

115 160

Trademarks

17 22
Show all operating metrics
Report incorrect company information

BioTelemetry Online and Social Media Presence

Embed Graph
Report incorrect company information

BioTelemetry News and Updates

Increasing Huge Demand for Global Prescribed Health Apps Market 2022: Major Key Players Covered Like iHealth Lab, BioTelemetry Inc, AirStrip Technologies, Apple, Sanofi, LifeWatch AG

This report presents a 360-degree overview of the competitive scenario of the Global Prescribed Health Apps market. The report further projects the size and valuation of the global market in the coming forecast period. The report also presents a thorough qualitative and quantitative data affecting t…

mHealth (Mobile Healthcare) Ecosystem Market 2023: Global Services, Applications, Deployment Type, Regions and Opportunities, Key Players like Apple, AT&T, BioTelemetry, athenahealth

Qurate’s has announced the addition of the “mHealth (Mobile Healthcare) Ecosystem Market” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. Posted via Industry Today. Follow us on Twitter @IndustryToday

BioTelemetry, Inc. to Release Third Quarter 2018 Earnings Results on October 30, 2018

MALVERN, Pa., Oct. 18, 2018 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its third quarter 2018 earnings on Tuesday, October 30 at 4:00 PM Eastern Time.

US Ambulatory (ECG) Industry Business & Investment Opportunity (2018 – 2022) Market Research Reports 2022

Pune, India, 1st May 2018: WiseGuyReports announced addition of new report, titled “US Ambulatory Electrocardiography (ECG) Market: Industry Analysis & Outlook (2018-2022)”. Posted via Industry Today. Follow us on Twitter @IndustryToday

Latest News on - Prescribed Health Apps Global Market Trends & Opportunities

Wiseguyreports.Com Publish New Market Research Report On -“Prescribed Health Apps 2017 Global Market – Key Players, Size, Trends, Opportunities, Growth- Analysis to 2021” Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information

BioTelemetry Company Life and Culture

Report incorrect company information

BioTelemetry Frequently Asked Questions

  • When was BioTelemetry founded?

    BioTelemetry was founded in 2013.

  • How many employees does BioTelemetry have?

    BioTelemetry has 1,087 employees.

  • What is BioTelemetry revenue?

    Latest BioTelemetry annual revenue is $286.8 m.

  • What is BioTelemetry revenue per employee?

    Latest BioTelemetry revenue per employee is $263.8 k.

  • Who are BioTelemetry competitors?

    Competitors of BioTelemetry include RSP Systems, Genetesis and Inscopix.

  • Where is BioTelemetry headquarters?

    BioTelemetry headquarters is located at 102 1000 Cedar Hollow Rd, Malvern.

  • Where are BioTelemetry offices?

    BioTelemetry has offices in Malvern, San Diego, Chiyoda-ku, London and in 8 other locations.

  • How many offices does BioTelemetry have?

    BioTelemetry has 13 offices.